Bilinsky Igor Insider Trades

Insider Trading History

Track insider trading activity for Bilinsky Igor. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $445k 117,500 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$636k 117,500 shares
$5.41
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $477k 125,766 shares
Last Trade
Mar 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$76.2k 16,628 shares
$4.58
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $540k 142,394 shares
Last Trade
Mar 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$143k 31,246 shares
$4.58
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $237k 62,504 shares
Last Trade
Mar 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$143k 31,246 shares
$4.58
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $133k 35,159 shares
Last Trade
Mar 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$33.3k 8,790 shares
$3.79
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Mar 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$13.3k 3,517 shares
$3.79
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $447k 118,051 shares
Last Trade
Mar 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$46.6k 12,307 shares
$3.79
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $421k 111,148 shares
Last Trade
Mar 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$26.2k 6,903 shares
$3.79
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $401k 105,744 shares
Last Trade
Dec 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.82k 1,786 shares
$2.14
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $408k 107,530 shares
Last Trade
Dec 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.51k 3,516 shares
$2.14
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $13.3k 3,517 shares
Last Trade
Dec 02, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.51k 3,516 shares
$2.14
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $411k 108,478 shares
Last Trade
Dec 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.6k 8,789 shares
$2.23
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $167k 43,949 shares
Last Trade
Dec 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.6k 8,789 shares
$2.23
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $394k 104,014 shares
Last Trade
Dec 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$9.95k 4,464 shares
$2.23
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $402k 105,939 shares
Last Trade
Sep 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$27k 12,306 shares
$2.19
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $378k 99,689 shares
Last Trade
Sep 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$13.7k 6,250 shares
$2.19
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $379k 99,883 shares
Last Trade
Jun 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$21.7k 12,305 shares
$1.76
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $355k 93,633 shares
Last Trade
Jun 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$11k 6,250 shares
$1.76
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $355k 93,750 shares
Last Trade
Mar 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$380k 93,750 shares
$4.05
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $332k 87,578 shares
Last Trade
Mar 03, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$135k 33,302 shares
$4.04
$3.79

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up